Ge Long Hui·2025-12-28 13:21Core Viewpoint - The company has received approval from the National Medical Products Administration for the registration of a freeze-dried human rabies vaccine (Vero cells), which will enhance its product portfolio and competitiveness in the vaccine market [1] Group 1 - The company, Guangzhou Baiyunshan Biological Products Co., Ltd., has obtained the drug registration certificate for the freeze-dried human rabies vaccine (Vero cells) [1] - The vaccine is intended for the prevention of rabies [1] - The approval will allow the company to enrich its product structure and improve its competitiveness in the vaccine market [1] Group 2 - Baiyunshan Biological will actively commence production of the freeze-dried human rabies vaccine in accordance with relevant requirements [1] - The product will be available for sale after obtaining the biological product batch release certificate from the National Medical Products Administration [1]